Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
American Journal of Physiology. Heart and Circulatory Physiology|April 16, 2013
B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring modelYan Li, Xizhong Cui, Steven B Solomon, et al.
Blood|September 18, 2024
Hemoglobin-based transfusion strategies for cardiovascular and other diseases: restrictive, liberal, or neither?Charles Natanson, Willard N Applefeld, Harvey G Klein
Current Opinion in Pediatrics|April 19, 2015
The influence of the storage lesion(s) on pediatric red cell transfusionKenneth E Remy, Charles Natanson, Harvey G Klein
Toxins|November 10, 2011
The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shockCaitlin W Hicks, Xizhong Cui, Daniel A Sweeney, et al.
British Journal of Haematology|January 28, 2014
Does prolonged storage of red blood cells cause harm?Willy A Flegel, Charles Natanson, Harvey G Klein
Critical Care (London, England)|June 17, 2016
Increased body mass index and adjusted mortality in ICU patients with sepsis or septic shock: a systematic review and meta-analysisDominique J Pepper, Junfeng Sun, Judith Welsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2012
Excess deaths associated with tigecycline after approval based on noninferiority trialsParitosh Prasad, Junfeng Sun, Robert L Danner, et al.
Reviews in Medical Virology|April 13, 2022
Comprehensive adjusted outcome data are needed to assess the impact of immune checkpoint inhibitors in cancer patients with COVID-19: Results of a systematic review and meta-analysisSamuel J Minkove, Junfeng Sun, Yan Li, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 24, 2007
A canine model of septic shock: balancing animal welfare and scientific relevancePeter C Minneci, Katherine J Deans, Bernie Hansen, et al.
Plos One|August 11, 2017
A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and resultsWanying Xu, Lernik Ohanjanian, Junfeng Sun, et al.
Pageof 13